Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T19:16:15.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added; Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.2 were removed.
    Difference
    0.2%
    Check dated 2026-03-12T14:32:44.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed as a related topic.
    Difference
    0.2%
    Check dated 2026-03-05T11:13:18.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Removed Melanoma and related topics (MedlinePlus Genetics) from the Related Topics section. This primarily affects navigation and context without changing the study details.
    Difference
    0.2%
    Check dated 2026-02-26T05:55:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Melanoma and related topics MedlinePlus Genetics were added, and the revision label was updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-11T23:42:32.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision added: v3.4.1. Melanoma and MedlinePlus Genetics were removed from related topics, along with the Revision: v3.4.0 entry.
    Difference
    0.2%
    Check dated 2026-02-04T22:58:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.